Candesartan 8 mg Tablets (Candesartan Cilexetil)

Adult dose

1. Essential Hypertension Adults: The recommended initial and maintenance dose is 8 to 16 mg of Candesartan Cilexetil, taken orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment at 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. The maximum effect is observed within 4 weeks of starting treatment. 2. Heart Failure Adults: The recommended starting dose is 4 mg once daily.

Child dose

Safety and efficacy for adolescents and children under 18 years have not been established.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals who are allergic to it or its components, women who are pregnant or breastfeeding, patients with severe liver disease or biliary obstruction, certain hereditary angioedema patients, primary aldosteronism patients, or those with lactose intolerance. Elderly individuals, patients with hyperkalemia, liver disease, heart valve disease, ischemic heart disease, or cerebrovascular disorders, patients with renal artery stenosis, those with reduced intravascular blood volume, reduced kidney function, recent kidney transplant recipients, and children and adolescents under 18 years should use this medication with caution. Possible side effects include dizziness, back pain, respiratory infections, and, in rare cases, serious side effects such as blood abnormalities, liver dysfunction, angioedema, rhabdomyolysis, and acute kidney failure. If any abnormal symptoms occur, consult a doctor immediately. Patients with heart failure or reduced kidney function should have their serum potassium and creatinine levels monitored regularly, as well as close observation of blood pressure and renal function. There may be interactions with other antihypertensive agents, potassium-sparing diuretics, and nonsteroidal anti-inflammatory drugs, so if you are taking other medications, be sure to inform your healthcare provider. Women who are planning to become pregnant or may be pregnant should not take this medication, and breastfeeding women should avoid taking it or stop breastfeeding. Safety and efficacy for individuals under 18 years have not been established, so it is advisable not to use it in this age group. For the elderly, there is a risk of excessive blood pressure lowering leading to conditions such as cerebral infarction, so care should be taken when administering. In case of overdose, symptoms such as symptomatic hypotension, dizziness, or rapid heartbeat may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and not transferred to other containers for safety.

Serious side effects

Hives, angioedema (swelling of the face, lips, tongue, throat), cold sweat, jaundice, paralysis, kidney damage, acute kidney failure, severe rash, blisters, skin peeling, pain in oral/eye mucosa, difficulty breathing, respiratory distress, shock, fainting, loss of consciousness

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, paresthesia, dyspepsia, gastroenteritis, tachycardia, palpitations, increased creatine kinase (CK), hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, drowsiness, rash, increased sweating,

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best kept at room temperature between 1°C and 30°C.

Appearance

Light pink, round tablets with a convex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle